TP53 and neoplasm: This raises the possibility that tumor suppressor phenotypes may be missed in mutant strains of both canonical p53-associated protein-coding genes and p53-associated lncRNAs when experimental design assumes a highly penetrant tumor-prone phenotype similar to that of p53 knockout animals and relies on decreased over-all survival as the only indicator of in vivo spontaneous tumor suppression.